Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Pfizer historical data, for real-time data please try another search
31.20 -0.10    -0.32%
05/10 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US7170811035 
S/N:  852009
  • Volume: 35
  • Bid/Ask: 31.20 / 31.40
  • Day's Range: 31.20 - 31.20
Pfizer 31.20 -0.10 -0.32%

NYSE:PFE Financials

 
A brief overview of the NYSE:PFE financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Pfizer over time.

For the six months ended 03 July 2016, Pfizer Inc. revenues increased 15% to $26.15B. Net income applicable to common stockholders excluding extraordinary items increased 1% to $5.03B. Revenues reflect Operating Segment-Global Established Pharmaceutical increase of 17% to $5.97B, Operating Segment-Global Vaccines, Oncology and Consumer Hea increase of 8% to $3.39B, United States segment increase of 33% to $6.63B.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

PFE Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Jun 29, 2015 Mar 29, 2015 Dec 31, 2014 Sep 28, 2014
Total Revenue 11853 10864 13118 12361
Gross Profit 9690 9035 10433 10006
Operating Income 3679 3163 1903 3740
Net Income 2626 2375 1229 2667

PFE Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Jun 29, 2015 Mar 29, 2015 Dec 31, 2014 Sep 28, 2014
Total Assets 160640 169274 171362
Total Liabilities 93336 97973 93374
Total Equity 67304 71301 77988

PFE Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Jun 29, 2015 Mar 29, 2015 Dec 31, 2014 Sep 28, 2014
Period Length: 0 Months 3 Months 12 Months 9 Months
Cash From Operating Activities 684 16883 11485
Cash From Investing Activities 6592 -5654 -4140
Cash From Financing Activities -6982 -9986 -7060
Net Change in Cash 220 1160 255
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
MOSHE LION
MOSHE LION Apr 26, 2024 12:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In your opinion it could go back to $40?
ARINSON S
ARINSON S Apr 26, 2024 12:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great entry price to Long
Leo Tim
Leo Tim Apr 25, 2024 8:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
intelligent science beauty technology psychypnotherapeuticlinicanewistech psychypnotherapist intellact far more advanced intellactuallist standard and firm wise decision state of the ART worlds most needed revelation
Donald Lowe
Donald Lowe Apr 25, 2024 12:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So true. Take heart. There's always support at zero. The price per share is now $16.00 less than when he took over as CEO in 2019.
George Galloway
George Galloway Apr 25, 2024 12:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
working hard towards another milestone or better known as another 52 week low
Kevin Lim
Kevin Lim Apr 25, 2024 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell
Kevin Parker
Kevin Parker Apr 09, 2024 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I appreciate what Pfizer does... But where are the cancer vaccines 9ther companies are developing?
Jay Clerk
Jay Clerk Apr 09, 2024 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They make more off treating it then treating the side effectswith more pills to treat the side effects from the pills and so on
Petru Zogo
Petru Zogo Apr 02, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer is in Europe in the middle of a scandal of proportions together with the president Ursula from. EU because of the strange contracts made during the Covid19 epidemic
Joe McKela
Joe McKela Apr 02, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Corruption, bribery, blackmail, the regular big pharma MO.
ali can
ali can Mar 25, 2024 3:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
George Galloway
George Galloway Mar 22, 2024 4:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Leadership has to be removed to regain the trust of investors.
Joe McKela
Joe McKela Mar 22, 2024 4:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No, it is corrupt to its core and huge lawsuits will follow.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email